id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2020-E-2365-0007,FDA,FDA-2020-E-2365,Notice of Final Determination and Requirement for Election Letter,Other,Letter(s),2024-02-21T05:00:00Z,2024,2,2024-02-21T05:00:00Z,,2024-02-21T21:47:41Z,,0,0,09000064863ee820
FDA-2020-E-2365-0006,FDA,FDA-2020-E-2365,Letter to U S Patent and Trademark Office,Other,Letter(s),2023-05-11T04:00:00Z,2023,5,2023-05-11T04:00:00Z,,2023-05-11T13:55:45Z,,0,0,09000064859ef969
FDA-2020-E-2365-0005,FDA,FDA-2020-E-2365,Determination of Regulatory Review Period for Purposes of Patent Extension; NURTEC ODT,Notice,Determinations,2022-09-23T04:00:00Z,2022,9,2022-09-23T04:00:00Z,2022-11-23T04:59:59Z,2022-09-23T14:07:09Z,2022-20634,0,0,090000648535bafa
FDA-2020-E-2365-0004,FDA,FDA-2020-E-2365,"Letter from FDA CDER to U.S, Patent and Trademark Office",Other,Letter(s),2022-09-08T04:00:00Z,2022,9,2022-09-08T04:00:00Z,,2022-09-08T19:45:17Z,,0,0,09000064852d06c2
FDA-2020-E-2365-0003,FDA,FDA-2020-E-2365,Letter to U S Patent and Trademark Office,Other,Letter(s),2021-03-01T05:00:00Z,2021,3,2021-03-01T05:00:00Z,,2021-03-01T18:40:08Z,,0,0,0900006484a58011
FDA-2020-E-2365-0002,FDA,FDA-2020-E-2365,"Patent Term Extension Application for NURTEC ODT® Patent No 8,759,372",Other,Application,2020-12-31T05:00:00Z,2020,12,2020-12-31T05:00:00Z,,2020-12-31T15:04:43Z,,0,0,09000064849d63e4
FDA-2020-E-2365-0001,FDA,FDA-2020-E-2365,Letter from U S Patent and Trademark Office,Other,Letter(s),2020-12-31T05:00:00Z,2020,12,2020-12-31T05:00:00Z,,2020-12-31T15:03:44Z,,0,0,09000064849d63e3